What are you looking for?
A review of adverse events found relatively low complication rates associated with the Hydrus Microstent, iStent inject W, and iStent infinite glaucoma devices, according to a poster presented at the...
Stand-alone iStent infinite trabecular micro-bypass substantially reduced mean diurnal intraocular pressure (IOP) in patients with advanced to refractory open-angle glaucoma (OAG) who had failed prior medical or surgical treatment, according to... ...
Hispanic patients are more likely to face delays in undergoing rhegmatogenous retinal detachment (RRD) repair while women and minorities are less likely to receive surgical intervention for an RRD after...
Patients with type 2 diabetes who underwent bariatric surgery had fewer cases of all and sight-threatening diabetic retinopathy (DR) compared to obese patients who received medical management alone, according to...
In this study, data from the IRIS Registry on 441,517 eyes was used to analyze delayed retinal breaking after initial posterior vitreous detachment (PVD). Overall, 2.37% (10,454) of eyes had...
Despite the session topic focusing on surgery for patients with inactive thyroid eye disease (TED), Louis A Mawn, MD, Professor Ophthalmology and Neurological Surgery, Vanderbilt University Medical Center told attendees...
A study compared the iStent Inject, Kahook Dual Blade (KDB), Trabectome, and Hydrus Microstent and found KDB to be most cost-effective in terms of cost per mmHG of IOP reduction....
Interim treatment with brolucizumab in eyes with neovascular age-related macular degeneration (nAMD) after a suboptimal response to a fixed aflibercept, ranibizumab, or bevacizumab regimen resulted in anatomic improvements that were...
Results from a retrospective review showed a 30-mcg dose of intravitreal bevacizumab is as effective as a 625-mcg dose for retinopathy of prematurity (ROP) treatment, with subsequent laser treatment rates...